Rediscovering Diazaborines: Synthesis and Bioactivity Profiling of Boron-Containing FabI Inhibitors against Gram-Negative Bacteria
Abstract
infection at the therapeutic dose of 1.13 and 2.81 mg/kg, demonstrating efficacy similar to ciprofloxacin.
Fields of Study & Subjects
Organoboron and organosilicon chemistry
Antimicrobial agents and applications
Microbial Natural Products and Biosynthesis
Publication details
- Journal / source
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Volume
- 69
- Issue
- 4
- Pages
- 3796–3810
- Publication date
- 7 February 2026
- Language
- EN